Degradable clostridial toxins

Details for Australian Patent Application No. 2005279741 (hide)

Owner Allergan, Inc.

Inventors Aoki, Kei Roger; Steward, Lance E.; Gilmore, Marcella A.; Fernandez-Salas, Ester; Li, Shengwen; Francis, Joseph A.

Agent Davies Collison Cave

Pub. Number AU-B-2005279741

PCT Pub. Number WO2006/026780

Priority 10/931,719 01.09.04 US

Filing date 1 September 2005

Wipo publication date 9 March 2006

Acceptance publication date 6 October 2011

International Classifications

C07K 14/33 (2006.01) Peptides having more than 20 amino acids

C07K 14/705 (2006.01) Peptides having more than 20 amino acids

Event Publications

22 March 2007 PCT application entered the National Phase

  PCT publication WO2006/026780 Priority application(s): WO2006/026780

6 October 2011 Application Accepted

  Published as AU-B-2005279741

2 February 2012 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005279758-Method and device for diagnosing and treating insulin-like growth factor deficiency disorders

2005279737-Methods and apparatus for the transmission of configuration information to wireless terminals in a wireless communication network